» Articles » PMID: 25299337

Anticytolytic Screen Identifies Inhibitors of Mycobacterial Virulence Protein Secretion

Overview
Publisher Cell Press
Date 2014 Oct 10
PMID 25299337
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Mycobacterium tuberculosis (Mtb) requires protein secretion systems like ESX-1 for intracellular survival and virulence. The major virulence determinant and ESX-1 substrate, EsxA, arrests phagosome maturation and lyses cell membranes, resulting in tissue damage and necrosis that promotes pathogen spread. To identify inhibitors of Mtb protein secretion, we developed a fibroblast survival assay exploiting this phenotype and selected molecules that protect host cells from Mtb-induced lysis without being bactericidal in vitro. Hit compounds blocked EsxA secretion and promoted phagosome maturation in macrophages, thus reducing bacterial loads. Target identification studies led to the discovery of BTP15, a benzothiophene inhibitor of the histidine kinase MprB that indirectly regulates ESX-1, and BBH7, a benzyloxybenzylidene-hydrazine compound. BBH7 affects Mtb metal-ion homeostasis and revealed zinc stress as an activating signal for EsxA secretion. This screening approach extends the target spectrum of small molecule libraries and will help tackle the mounting problem of antibiotic-resistant mycobacteria.

Citing Articles

Toward Virulence Inhibition: Beyond Cell Wall.

Kotliarova M, Shumkov M, Goncharenko A Microorganisms. 2025; 13(1).

PMID: 39858789 PMC: 11767696. DOI: 10.3390/microorganisms13010021.


Modulating mycobacterial envelope integrity for antibiotic synergy with benzothiazoles.

Habjan E, Lepioshkin A, Charitou V, Egorova A, Kazakova E, Ho V Life Sci Alliance. 2024; 7(7).

PMID: 38744470 PMC: 11094368. DOI: 10.26508/lsa.202302509.


TcrXY is an acid-sensing two-component transcriptional regulator of Mycobacterium tuberculosis required for persistent infection.

Stupar M, Tan L, Kerr E, De Voss C, Forde B, Schulz B Nat Commun. 2024; 15(1):1615.

PMID: 38388565 PMC: 10883919. DOI: 10.1038/s41467-024-45343-7.


: Pathogenesis and therapeutic targets.

Yang J, Zhang L, Qiao W, Luo Y MedComm (2020). 2023; 4(5):e353.

PMID: 37674971 PMC: 10477518. DOI: 10.1002/mco2.353.


Characterization of Two Novel Inhibitors of the Mycobacterium tuberculosis Cytochrome Complex.

Gries R, Dal Molin M, Chhen J, van Gumpel E, Dreyer V, Niemann S Antimicrob Agents Chemother. 2023; 67(7):e0025123.

PMID: 37358461 PMC: 10353358. DOI: 10.1128/aac.00251-23.